4974 — Takara Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapFalling Star

Annual balance sheet for Takara Bio, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	19,033	20,266	25,993	23,633	51,847
Net Total Accounts Receivable
Net Total Receivables	8,563	9,046	12,585	17,804	12,448
Total Inventory
Total Other Current Assets
Total Current Assets	35,275	38,387	49,115	68,141	77,569
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	21,404	24,213	29,766	36,395	40,956
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	71,040	75,009	89,750	115,712	129,202
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6,017	6,248	13,191	17,380	14,375
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	7,030	8,513	15,568	19,839	16,983
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	64,010	66,496	74,182	95,873	112,219
Total Liabilities & Shareholders' Equity	71,040	75,009	89,750	115,712	129,202
Total Common Shares Outstanding